Clinical Trial Update: Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer [Phase 2]

View source ↗

Summary

Clinical trial update notes that a Phase 2 study of irofulvene in stage III/IV pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Irofulvene (irofulvene)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED